Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

A short, visual guide to every ruling on Obamacare’s subsidies

When the Supreme Court rules in King v. Burwell, the new Obamacarechallenge, its judges won’t be the first to grapple with whether the health law’s subsidies on the federal marketplace are legal.

Since early 2014, five separate courts have issued rulings on the issue in three separate health law challenges. Three courts have ruled in the Affordable Care Act’s favor; two have ruled against the subsidies.

Even for those following the case closely, it can be difficult to keep track of all those decisions. That’s why my colleague Anand Katakam and I put together this timeline of all the court decisions:

(Anand Katakam / Vox)

Here’s a bit more on the three lawsuits:

Pruitt v. Burwell

This challenge, filed in late 2012 by Oklahoma Attorney General Scott Pruitt, was the first lawsuit to argue that Obamacare’s subsidies on the federal marketplace were illegal. It’s important because it marked the first time a plaintiff actually got on board with a legal argument that had been circulating in conservative legal circles for about a year. Even though Pruitt was filed first, it has moved the slowest through the courts. It was only this past fall that a district court ruled in Oklahoma’s favor, finding the Obama administration’s decision to administer subsidies on the federal marketplace to be “ arbitrary, capricious, an abuse of discretion or otherwise not in accordance with law.”

Important documents:

Halbig v. Burwell

Challengers filed in court in May 2013, about six months after the Pruitt case. The Competitive Enterprise Institute is funding this case, as well as King v. Burwell. Halbig is different from Pruitt because it includes private citizens and businesses as its plaintiffs. This was strategic on the part of the law’s challengers: they wanted to give courts as many different arguments as possible to choose from. In Halbig, a district court initially ruled in the government’s favor — but the Court of Appeals for the District of Columbia reversed that decision in July. This is the other ruling against the law, alongside Pruitt.

Important documents:

King v. Burwell

This is the lawsuit that the Supreme Court decided to hear in November. Like Halbig, it also includes private citizens and business owners as challengers to the law. Both courts that have heard the King argument have ruled in the Obama administration’s favor, finding the health law’s subsidies to be legal.

Important documents

There is a fourth challenge to the health law’s subsidies, Indiana v. IRS. This challenge includes the state of Indiana as well as dozens of Indiana school districts, also arguing against the health law’s subisidies. We did not, however, include it in our timeline as there have not yet been any court decisions on the case.

This post is indebted to Michael Cannon, who has aggregated these documents (as well as many others) in his Forbes guide to the health law challenges.

More in Politics

Podcasts
The Supreme Court abortion pills case, explainedThe Supreme Court abortion pills case, explained
Podcast
Podcasts

How Louisiana brought mifepristone back to SCOTUS.

By Peter Balonon-Rosen and Sean Rameswaram
Politics
Trump’s China policy is nearly the exact opposite of what everyone expectedTrump’s China policy is nearly the exact opposite of what everyone expected
Politics

As Trump heads to China, attention and resources are being shifted from Asia to yet another war in the Middle East.

By Joshua Keating
Politics
Are far-right politics just the new normal?Are far-right politics just the new normal?
Politics

Liberals are preparing for a longer war with right-wing populists than they once expected.

By Zack Beauchamp
The Logoff
Flavored vapes doomed Trump’s FDA headFlavored vapes doomed Trump’s FDA head
The Logoff

Why Marty Makary is out at the FDA, briefly explained.

By Cameron Peters
Politics
Virginia Democrats’ irresponsible new plan to save their gerrymanderVirginia Democrats’ irresponsible new plan to save their gerrymander
Politics

Democrats just handed the Supreme Court’s Republicans a loaded weapon.

By Ian Millhiser
The Logoff
Can Trump lower gas prices?Can Trump lower gas prices?
The Logoff

What suspending the gas tax would mean for you, briefly explained.

By Cameron Peters